Amgen Inc. delivered strong operational performance across the board in 2025, and you can see that in the breadth of our business. Three of these, Repatha, Evenity, and TestSpire, all grew by more ...
Jeffrey will start with an overview followed by Bryan's detail of our Q4 and fiscal year 2025 results, as well as Q1 2026 guidance. This being his last conference call as CEO, after Q&A, we'll turn ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results